These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9100667)

  • 1. Variant late infantile neuronal ceroid-lipofuscinosis: pathology and biochemistry.
    Tyynelä J; Suopanki J; Santavuori P; Baumann M; Haltia M
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):369-75. PubMed ID: 9100667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pathology in NCL.
    Anderson GW; Goebel HH; Simonati A
    Biochim Biophys Acta; 2013 Nov; 1832(11):1807-26. PubMed ID: 23200925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingolipid activator proteins in the neuronal ceroid-lipofuscinoses: an immunological study.
    Tyynelä J; Baumann M; Henseler M; Sandhoff K; Haltia M
    Acta Neuropathol; 1995; 89(5):391-8. PubMed ID: 7618436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of sphingolipid activator proteins (SAPs) A and D in granular osmiophilic deposits in miniature Schnauzer dogs with ceroid-lipofuscinosis.
    Palmer DN; Tyynelä J; van Mil HC; Westlake VJ; Jolly RD
    J Inherit Metab Dis; 1997 Mar; 20(1):74-84. PubMed ID: 9061571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal ceroid-lipofuscinosis--late-infantile or Jansky-Bielschowsky type--revisited.
    Goebel HH; Gerhard L; Kominami E; Haltia M
    Brain Pathol; 1996 Jul; 6(3):225-8. PubMed ID: 8864279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical late infantile and juvenile forms of neuronal ceroid lipofuscinosis and their diagnostic difficulties.
    Wiśniewski KE; Zhong N; Kida E; Kaczmarski W; Kaczmarski A; Connell F; Brooks SS; Brown WT
    Folia Neuropathol; 1997; 35(2):73-9. PubMed ID: 9377079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuronal ceroid-lipofuscinoses.
    Goebel HH
    J Child Neurol; 1995 Nov; 10(6):424-37. PubMed ID: 8576551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuronal ceroid-lipofuscinoses: from past to present.
    Haltia M
    Biochim Biophys Acta; 2006 Oct; 1762(10):850-6. PubMed ID: 16908122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders.
    Elleder M; Sokolová J; Hrebícek M
    Acta Neuropathol; 1997 Apr; 93(4):379-90. PubMed ID: 9113203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant adult neuronal ceroid lipofuscinosis: a novel form of NCL with granular osmiophilic deposits without palmitoyl protein thioesterase 1 deficiency.
    Nijssen PC; Ceuterick C; van Diggelen OP; Elleder M; Martin JJ; Teepen JL; Tyynelä J; Roos RA
    Brain Pathol; 2003 Oct; 13(4):574-81. PubMed ID: 14655761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuronal ceroid-lipofuscinoses. Recent advances.
    Goebel HH; Sharp JD
    Brain Pathol; 1998 Jan; 8(1):151-62. PubMed ID: 9458173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuronal ceroid lipofuscinosis. Closing chapter of a long story].
    Elleder M
    Cesk Patol; 2000 May; 36(2):43-59. PubMed ID: 10916928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Storage of saposins A and D in infantile neuronal ceroid-lipofuscinosis.
    Tyynelä J; Palmer DN; Baumann M; Haltia M
    FEBS Lett; 1993 Sep; 330(1):8-12. PubMed ID: 8370464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linkage analysis of late-infantile neuronal ceroid-lipofuscinosis.
    Sharp J; Savukoski M; Wheeler RB; Harris J; Järvelä I; Peltonen L; Gardiner M; Williams R
    Am J Med Genet; 1995 Jun; 57(2):348-9. PubMed ID: 7668361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipid activator proteins (SAPs) in neuronal ceroid lipofuscinoses (NCL).
    Tyynelä J; Suopanki J; Baumann M; Haltia M
    Neuropediatrics; 1997 Feb; 28(1):49-52. PubMed ID: 9151322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased urine concentration of subunit c of mitochondrial ATP synthase in neuronal ceroid lipofuscinoses patients.
    Wisniewski KE; Golabek AA; Kida E
    J Inherit Metab Dis; 1994; 17(2):205-10. PubMed ID: 7967475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic heterogeneity in neuronal ceroid lipofuscinosis (NCL): evidence that the late-infantile subtype (Jansky-Bielschowsky disease; CLN2) is not an allelic form of the juvenile or infantile subtypes.
    Williams R; Vesa J; Järvelä I; McKay T; Mitchison H; Hellsten E; Thompson A; Callen D; Sutherland G; Luna-Battadano D
    Am J Hum Genet; 1993 Oct; 53(4):931-5. PubMed ID: 8213822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in neuropathology of the neuronal ceroid lipofuscinoses.
    Goebel HH; Schochet SS; Jaynes M; Brück W; Kohlschütter A; Hentati F
    Mol Genet Metab; 1999 Apr; 66(4):367-72. PubMed ID: 10191130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 11p15 and 15q21-23.
    Sharp JD; Wheeler RB; Lake BD; Savukoski M; Järvelä IE; Peltonen L; Gardiner RM; Williams RE
    Hum Mol Genet; 1997 Apr; 6(4):591-5. PubMed ID: 9097964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of storage pathology in prenatal CLN5-deficient sheep neural cultures by lentiviral gene therapy.
    Hughes SM; Hope KM; Xu JB; Mitchell NL; Palmer DN
    Neurobiol Dis; 2014 Feb; 62():543-50. PubMed ID: 24269732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.